Clinical Drug Experience Knowledgebase

22q11 Deletion Syndrome (Phase 3)

Acute Coronary Syndrome (Phase 1)

Alcoholism (Phase 4)

Anxiety Disorders (Phase 3)

Autistic Disorder (Phase 3)

Binge-Eating Disorder (Phase 2)

Bipolar Disorder (Phase 4)

Bulimia (Phase 2)

Cognition Disorders (Phase 3)

Cognitive Dysfunction (Phase 3)

Compulsive Personality Disorder (Phase 2)

Coronary Artery Disease (Phase 1)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Depressive Disorder, Treatment-Resistant (Phase 3)

Disease (Phase 4)

Dyskinesias (Phase 2)

Dysthymic Disorder (Phase 4)

Feeding and Eating Disorders (Phase 2)

Heart Diseases (Phase 1)

Hyperhidrosis (Phase 4)

Insulin Resistance (Phase 4)

Marijuana Abuse (Phase 3)

Mental Disorders (Phase 4)

Metabolic Syndrome (Phase 4)

Obsessive-Compulsive Disorder (Phase 2)

Personality Disorders (Phase 2)

Psychoses, Substance-Induced (Phase 4)

Psychotic Disorders (Phase 4)

Schizophrenia (Phase 4)

Schizotypal Personality Disorder (Phase 2)

Shared Paranoid Disorder (Phase 4)

Stress Disorders, Post-Traumatic (Phase 2)

Stress Disorders, Traumatic (Phase 2)

Substance-Related Disorders (Phase 3)

Suicidal Ideation (Phase 2)

Syndrome (Phase 4)

Tardive Dyskinesia (Phase 2)

Tobacco Use Disorder (Phase 4)